The influence of drug-exposure conditions on the development of resistance to methotrexate or ZD1694 in cultured human leukaemia cells

International Journal of Cancer

Volumn 66, Issue 1, 1996, Pages 29-36

  Takemura, Yuzuru ^a   Kobayashi, Hiroyuki ^a   Gibson, William ^b   Kimbell, Rosemary ^b   Miyachi, Hayato ^c   Jackman, Ann L ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; FOLYLPOLYGLUTAMATE SYNTHASE; GAMMA GLUTAMYL HYDROLASE; MESSENGER RNA; METHOTREXATE; RALTITREXED;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG EXPOSURE; DRUG RESISTANCE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOID CELL LINE; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; DRUG RESISTANCE; GAMMA-GLUTAMYL HYDROLASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEUKEMIA; METHOTREXATE; PEPTIDE SYNTHASES; PTEROYLPOLYGLUTAMIC ACIDS; QUINAZOLINES; RNA, MESSENGER; TETRAHYDROFOLATE DEHYDROGENASE; THIOPHENES; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED;

EID: 0029876807     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960328)66:1<29::AID-IJC6>3.0.CO;2-0     Document Type: Conference Paper

References (29)

1. BERINO, J.R., SRIMATKANDADA, S., CARMAN, M.D., JASTREBOFF, M., MEHIMAN L., MEDINA, W.D., MINI, E., MOROSON, B.A., CASHMORE, A R and DUBE, S.K., Drug resistance. new approaches to treatment. In P Chandra (ed.), New experimental modalities in the control of neoplasia. pp. 183-193, Plenum Press, New York (1986).
2. BISSEI, G.M.F., PAWELCZAK, K., JACKMAN, A.L., CALVERT, A.H. and HUGHES L.R., The synthesis and thymidylate-synthase-inhibiton, activity of the poly-γ-glutamyl conjugates of ICI D1694 and other quinazoline anti-folates. J. med. Chem., 35, 859-866 (1992).
3. CALVERT, A.H., JONES, T.R., DADY, P.J., GRZELAKOWSKA-SZTABERT, B., PAINE, R.M., TAYLOR, G.A. and HARRAP, K.R., Quinazoline antifolates with dual biochemical loci of action. Biochemical and biological studies directed towards overcoming methotrexate resistance. Europ J. Cancer. 16, 713-722 (1980).
4. CHABNER, B.A., ALLEGRA, C.J., CURT, G.A., CLENDENIN, N.J., BARAM, J., KOIZUMI, S., DRAKE, J.C and JOLIVET, J., Polyslutamation of methotrexate. J. clin. Invest., 76, 907-912 (1985).
5. CHOMCZYNSKI, P., One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal. Biochem., 201, 134-139 (1992).
6. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid-guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
7. GALIVAN, J., Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate, Mol. Pharmacol., 17, 105-110 (1980).
8. GARROW, T.A., ADMON, A. and SHANE, B., Expression cloning of a human cDNA encoding folylpoly(γ-glutamate) synthetase and determination of its primary structure. Proc. nat. Acad, Sci. (Wash.), 89, 9151-9155 (1992).
9. GIBSON, W., BISSET, G.M.F., MARSHAM, P.R., KELLAND, L.R., JUDSON, I.R. and JACKMAN, A.L., The measurement of polyglut0amate metabolites of the thymidylate-synthase inhibitor. ICI D1694. in mouse and human cultured cells. Biochem. Pharmacol., 45, 863-869 (1993).
10. 10-propargyl-5.8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies. Cancer Res., 46, 2810-2815 (1986).
11. JACKMAN, A.L., KELLAND, L.R., KIMBELL, R., BROWN, M., GIBSON, W., AHERNE, G.W., HARDCASTLE, A. and BOYLE, T., Mechanisms of acquired resistance to the quinazoline thymidylate-synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines. Bru. J. Cancer, 71, 914-924 (1995).
12. 10-substituted-5.8-dideazafolates. Advanc. Enzyme Regul., 31, 13-27 (1991b).
13. JACKMAN, A.L., TAYLOR, G.A., GIBSON, W., KIMBELL, R., BROWN, M., CALVERT, A.H., JUDSON, I.R. and HUGHES, L.R., ICI D1694. a quinazoline anti-folate thymidylate-synthase inhibitor that is a potent inhibitor of L1210 tumor-cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res., 51, 5579-5586 (1991a).
14. JACKSON, R.C., HART, L.I. and HARRAP, K.R., Intrinsic resistance to methotrexate of cultured mammalian cells in relation to the inhibition kinetics of their dihydrofolate reductases. Cancer Res., 36, 1991-1997 (1976).
15. KANO, Y., OHNUMA, T. and HOLLAND, J.F., Folate requirements of methotrexate-resistant human acute-lymphoblastic-leukemia cell lines. Blood, 68, 586-591 (1986).
16. Li, W.W., WALTHAM, M., TONG, W., SCHWEITZER, B.I. and BERTINO, J.R., Increased activity of γ-glutamyl hydrolase in human sarcoma cell lines: a novel mechanism of intrinsic resistance to methotrexate. In: J.E. Ayling, M.G. Nair and C.M. Baugh (eds.), Chemistry and biology of pteridines and folates. Advanc. Exp. Med. Biol., 338, pp. 635-638, Plenum Press, New York (1993).
17. MCCLOSKEY, D.E., MCGUIRE, J.J., RUSSELL, C.A., ROWAN, B.G., BERTINO, J R., PIZZORNO, G. and MINI, E., Decreased folylpolyglutamate-synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sub-lines. J. biol. Chem., 266, 6181-6187 (1991).
18. MINOWADA, J., OHNUMA, T. and MOORE, G.E., Rosette-forming human lymphoid cell lines: I. Establishment and evidence for origin of thymus-derived lymphocytes. J nat. Cancer Inst., 49, 891-895 (1972).
19. MIYACHI, H., TAKEMURA, Y., KOBAYASHI, H. and ANDO, Y., Expression of variant dihydrofolate reductase with decreased binding affinity to anti-folates in MOLT-3 human leukemia cell lines resistant to trimetrexate. Cancer Lett., 88, 93-99 (1995).
20. 10-propargyl-5.8-dideazafolic acid: a novel folate-based thymidylate-synthase inhibitor. Cancer Res., 52, 1137-1143 (1992).
21. OHNUMA, T., LO, R.J., SCANLON, K.J., KAMEN, B.A., OHNOSHI, T., WOLMAN, S.R. and HOLLAND, J.F., Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro. Cancer Res., 45, 1815-1822 (1985).
22. PIZZORNO, G., MINI, E., CORONNELLO, M., MCGUIRE, J.J., MOROSON, B.A , CASHMORE, A R., DREYER, R.N., LIN, J.T., MAZZEI, T., PERIE, P. and BERTINO, J.R., Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug. Cancer Res.. 48, 2149-2155 (1988).
23. RHEE, M.S., WANG, Y., NAIR, M.G. and GALIVAN, J., Acquisition of resistance to antifolates caused by enhanced γ-glutamyl hydrolase activity. Cancer Res . 53, 2227-2230 (1993).
24. SIROTNAK, P.M., MOCCIO, D.M., GOUTAS, L.J., KELLEHER, L.E. and MONTGOMERY, J.A., Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate. metoprine. Cancer Res.. 42, 924-930 (1982).
25. TAKEMURA, Y., GIBSON, W., KIMBELL, R., KOBAYASHI, H., MIYACHI, H. and JACKMAN, A.L., Cellular pharmacokinetics of ZD1694 in cultured human leukaemia cells sensitive, or made resistant, to this drug. J. Cancer Res. clin. Oncol., 122, 109-117 (1996).
26. TAKEMURA, Y., KOBAYASHI, H., MIYACHI, H., HAYASHI, K., SEKIGUCHI, S. and OHNUMA, T., The influence of tumor cell density on cellular accumulation of doxorubicin or cisplatin in vitro. Cancer Chemother Pharmacol., 27, 417-422 (1991).
27. TAKEMURA, Y., OHNUMA, T., CHOU, T.C., OKANO, T. and HOLLAND, J.F., Biologic and pharmacologic effects of harringtonine on human leukemia-lymphoma cells. Cancer Chemother, Pharmacol., 14, 206-210 (1985).
28. TONG, W.P., LIN, S., LI, W.W., WALTHAM, M., GOKER, E. and BERTINO, J.R., Capillary electrophoresis of methotrexate polyglutamates and its application in evaluation of folylpolyglutamate hydrolase activity. Proc. Amer. Ass. Cancer Res., 35, 304 (1994).
29. WARD, W.H.J., KIMBELL, R. and JACKMAN, A.L., Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthase. Biochem. Pharmacol., 43, 2029-2031 (1992).